Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mullen

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
Annals of the New York Academy of Sciences|January 1, 1988
cis-5-alkoxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidine derivativesD M Maryniak, G B Mullen, J T Mitchell, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro antifungal activity and structure-activity relationship studies of novel cis-5-acyloxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidine derivativesD M Maryniak, G B Mullen, S D Allen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro antifungal activity of novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine derivativesT R DeCory, G B Mullen, J T Mitchell, et al.
Journal of Medicinal Chemistry|October 1, 1988
Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivativesG B Mullen, T R DeCory, J T Mitchell, et al.
American Journal of Obstetrics and Gynecology|February 1, 1995
Reduced placental villous tree elaboration in small-for-gestational-age pregnancies: relationship with umbilical artery Doppler waveformsM R Jackson, A J Walsh, R J Morrow, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 31, 2013
Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticlesAyman M Gebril, Dimitrios A Lamprou, Manal M Alsaadi, et al.
The Journal of Trauma|October 23, 1998
Pulmonary and systemic fat embolization after medullary canal pressurization: a hemodynamic and histologic investigation in the dogE H Schemitsch, D C Turchin, G I Anderson, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Novel 5-phenyl(or phenoxyalkyl)-3-(2-furanyl)-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines. In vitro antifungal activityG A Bennett, G B Mullen, J T Mitchell, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel 5-carbonyl derivatives of 3-phenyl-3-(1H-imidazol-1-ylmethyl)- 2-methyl-isoxazolidinesG A Bennett, G B Mullen, T R DeCory, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1995
Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsisT E Stewart, F Valenza, S P Ribeiro, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
Annals of the New York Academy of Sciences|January 1, 1988
cis-5-alkoxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidine derivativesD M Maryniak, G B Mullen, J T Mitchell, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro antifungal activity and structure-activity relationship studies of novel cis-5-acyloxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidine derivativesD M Maryniak, G B Mullen, S D Allen, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro antifungal activity of novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine derivativesT R DeCory, G B Mullen, J T Mitchell, et al.
Journal of Medicinal Chemistry|October 1, 1988
Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivativesG B Mullen, T R DeCory, J T Mitchell, et al.
American Journal of Obstetrics and Gynecology|February 1, 1995
Reduced placental villous tree elaboration in small-for-gestational-age pregnancies: relationship with umbilical artery Doppler waveformsM R Jackson, A J Walsh, R J Morrow, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 31, 2013
Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticlesAyman M Gebril, Dimitrios A Lamprou, Manal M Alsaadi, et al.
The Journal of Trauma|October 23, 1998
Pulmonary and systemic fat embolization after medullary canal pressurization: a hemodynamic and histologic investigation in the dogE H Schemitsch, D C Turchin, G I Anderson, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Novel 5-phenyl(or phenoxyalkyl)-3-(2-furanyl)-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines. In vitro antifungal activityG A Bennett, G B Mullen, J T Mitchell, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel 5-carbonyl derivatives of 3-phenyl-3-(1H-imidazol-1-ylmethyl)- 2-methyl-isoxazolidinesG A Bennett, G B Mullen, T R DeCory, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1995
Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsisT E Stewart, F Valenza, S P Ribeiro, et al.
Pageof 20